Backed by the VitaDAO community, the team from VitaRNA / ArtanBIO will be taking the stage tomorrow in St. Pete for the @spARKbyARK Innovation Showcase.
Leading the company are CEO @Bodeeeman, co-founder and COO @aschwartzphd, and co-founder and CSO @Mykalt45.
The group is currently advancing their lead program, ARTAN-102, through the preclinical phase. This initiative centers on a suppressor tRNA designed for a specific kind of nonsense mutation, precisely where an arginine codon converts into a stop codon.
Leading the company are CEO @Bodeeeman, co-founder and COO @aschwartzphd, and co-founder and CSO @Mykalt45.
The group is currently advancing their lead program, ARTAN-102, through the preclinical phase. This initiative centers on a suppressor tRNA designed for a specific kind of nonsense mutation, precisely where an arginine codon converts into a stop codon.